SA
PAAI

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 28.4 · elevated volatility

Overview →
11/19/26

Paradium.AI (PAAI)

Thursday
7:18 PM ET
ThesisRecent strategic partnerships and product launches indicate a strengthening market position and potential for revenue growth.

Revenue Outlook

MetricFY2025FY2026EFY2027E
Revenue$135M$84M$84M
Rev. Growth—-38.0%+0.5%
EPS$2.63$-0.19$-0.12
EPS Growth—-107%+36.8%
P/E0.2×NMNM
P/S0.2×0.3×0.3×
★ Analysts see FY2027 revenue reaching $84M — +0.5% growth in a single year.

What’s Driving the Stock

  1. 01Recent partnership with a leading healthcare provider to implement AI solutions, potentially increasing ARR by 15%.
  2. 02Launch of a new AI-driven analytics tool that has received positive feedback from beta users, indicating strong demand.
  3. 03Expansion into European markets with tailored solutions, targeting a 20% increase in international revenue.
  4. 04Increased investment in R&D leading to a 30% improvement in product performance metrics, enhancing competitive positioning.
  5. 05AI-driven digital transformation in enterprise software
  6. 06Increased focus on data privacy and compliance in AI applications
  7. 07Adoption rates of AI technologies in target industries, particularly healthcare and finance
  8. 08Partnerships with major software platforms for integration
FY2025 Snapshot
Revenue
$135M
EPS
$2.63
1Y Return
-67.4%

PAAI Chart

0.31.11.92.83.60.46PAAI Daily0.46Aug '26Sep '26Oct '26Nov '26

My Notes

  • "Our commitment to innovation and strategic partnerships is driving our growth trajectory."
  • Moat: Parium.AI's proprietary algorithms and industry-specific solutions provide a moderate barrier to entry against competitors.
  • growth - investors are likely drawn to the potential for rapid expansion in the AI sector.
  • Rising interest rates could impact client budgets for technology investments, potentially slowing growth.
  • Watch on earnings: Annual recurring revenue (ARR), Customer retention rate, Market share in AI application software.

One Sentence Summary:

The bull case is simple: analysts see revenue climbing from $84M to $84M as recent partnership with a leading healthcare provider to implement ai solutions, potentially increasing arr by 15%.

Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.